ID: ALA5283223

Max Phase: Preclinical

Molecular Formula: C21H24O2S2

Molecular Weight: 372.56

Associated Items:

Representations

Canonical SMILES:  COc1ccc(C2CCc3cc(C4SCCCCS4)ccc3O2)cc1

Standard InChI:  InChI=1S/C21H24O2S2/c1-22-18-8-4-15(5-9-18)19-10-6-16-14-17(7-11-20(16)23-19)21-24-12-2-3-13-25-21/h4-5,7-9,11,14,19,21H,2-3,6,10,12-13H2,1H3

Standard InChI Key:  IXLLLXKOFOCCGE-UHFFFAOYSA-N

Associated Targets(non-human)

L6 7924 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 372.56Molecular Weight (Monoisotopic): 372.1218AlogP: 6.02#Rotatable Bonds: 3
Polar Surface Area: 18.46Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.88CX LogD: 5.88
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.66Np Likeness Score: 0.16

References

1. Lepechkin-Zilbermintz V, Bareket D, Gonnord V, Steffen A, Morice C, Michaut M, Munder A, Korshin EE, Contreras JM, Cerasi E, Sasson S, Gruzman A..  (2023)  Moderately lipophilic 2-(Het)aryl-6-dithioacetals, 2-phenyl-1,4-benzodioxane-6-dithioacetals and 2-phenylbenzofuran-5-dithioacetals: Synthesis and primary evaluation as potential antidiabetic AMPK-activators.,  87  [PMID:37167713] [10.1016/j.bmc.2023.117303]

Source